The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines

Several protein vaccine candidates are among the COVID-19 vaccines in development. The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) has prepared a standardized template to describe the key considerations for the benefit-risk assessment of protein vaccines. This will help...

Full description

Autores:
Tipo de recurso:
Article of journal
Fecha de publicación:
2020
Institución:
Universidad de Bogotá Jorge Tadeo Lozano
Repositorio:
Expeditio: repositorio UTadeo
Idioma:
eng
OAI Identifier:
oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/13328
Acceso en línea:
https://www.sciencedirect.com/science/article/pii/S0264410X20308306?via%3Dihub
http://hdl.handle.net/20.500.12010/13328
https://doi.org/10.1016/j.vaccine.2020.06.044
Palabra clave:
Brighton Collaboration
CEPI
Vaccine
Benefit-risk
Safety
Protein
Recombinant
Peptide
Template
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
Rights
License
Acceso restringido
id UTADEO2_bd9281c0b461927d8593942a39efe017
oai_identifier_str oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/13328
network_acronym_str UTADEO2
network_name_str Expeditio: repositorio UTadeo
repository_id_str
dc.title.spa.fl_str_mv The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines
title The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines
spellingShingle The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines
Brighton Collaboration
CEPI
Vaccine
Benefit-risk
Safety
Protein
Recombinant
Peptide
Template
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
title_short The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines
title_full The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines
title_fullStr The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines
title_full_unstemmed The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines
title_sort The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines
dc.subject.spa.fl_str_mv Brighton Collaboration
CEPI
Vaccine
Benefit-risk
Safety
Protein
Recombinant
Peptide
Template
topic Brighton Collaboration
CEPI
Vaccine
Benefit-risk
Safety
Protein
Recombinant
Peptide
Template
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
dc.subject.lemb.spa.fl_str_mv Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
description Several protein vaccine candidates are among the COVID-19 vaccines in development. The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) has prepared a standardized template to describe the key considerations for the benefit-risk assessment of protein vaccines. This will help key stakeholders to assess potential safety issues and understand the benefit-risk of such a vaccine platform. The structured and standardized assessment provided by the template would also help contribute to improved public acceptance and communication of licensed protein vaccines.
publishDate 2020
dc.date.accessioned.none.fl_str_mv 2020-09-16T14:53:36Z
dc.date.available.none.fl_str_mv 2020-09-16T14:53:36Z
dc.date.created.none.fl_str_mv 2020-06-15
dc.type.local.spa.fl_str_mv Artículo
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_6501
format http://purl.org/coar/resource_type/c_6501
dc.identifier.issn.spa.fl_str_mv 0264-410X
dc.identifier.other.spa.fl_str_mv https://www.sciencedirect.com/science/article/pii/S0264410X20308306?via%3Dihub
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/20.500.12010/13328
dc.identifier.doi.spa.fl_str_mv https://doi.org/10.1016/j.vaccine.2020.06.044
identifier_str_mv 0264-410X
url https://www.sciencedirect.com/science/article/pii/S0264410X20308306?via%3Dihub
http://hdl.handle.net/20.500.12010/13328
https://doi.org/10.1016/j.vaccine.2020.06.044
dc.language.iso.spa.fl_str_mv eng
language eng
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_16ec
dc.rights.local.spa.fl_str_mv Acceso restringido
rights_invalid_str_mv Acceso restringido
http://purl.org/coar/access_right/c_16ec
dc.format.extent.spa.fl_str_mv 6 páginas
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Vaccine
dc.source.spa.fl_str_mv reponame:Expeditio Repositorio Institucional UJTL
instname:Universidad de Bogotá Jorge Tadeo Lozano
instname_str Universidad de Bogotá Jorge Tadeo Lozano
institution Universidad de Bogotá Jorge Tadeo Lozano
reponame_str Expeditio Repositorio Institucional UJTL
collection Expeditio Repositorio Institucional UJTL
bitstream.url.fl_str_mv https://expeditiorepositorio.utadeo.edu.co/bitstream/20.500.12010/13328/2/license.txt
https://expeditiorepositorio.utadeo.edu.co/bitstream/20.500.12010/13328/3/The%20Brighton%20Collaboration%20standardized%20template%20for%20collection%20of%20key%20information%20for%20benefit-risk%20assessment%20of%20protein%20vaccines.pdf
https://expeditiorepositorio.utadeo.edu.co/bitstream/20.500.12010/13328/4/The%20Brighton%20Collaboration%20standardized%20template%20for%20collection%20of%20key%20information%20for%20benefit-risk%20assessment%20of%20protein%20vaccines.png
https://expeditiorepositorio.utadeo.edu.co/bitstream/20.500.12010/13328/5/The%20Brighton%20Collaboration%20standardized%20template%20for%20collection%20of%20key%20information%20for%20benefit-risk%20assessment%20of%20protein%20vaccines.pdf.jpg
bitstream.checksum.fl_str_mv abceeb1c943c50d3343516f9dbfc110f
577f0dded44f9b81cbc5aacb5644ae3c
c45af434de2d32e6c8bc0434faf5d57d
fb4b23cc8fd4f8c0d08881f49ee2ec4d
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional - Universidad Jorge Tadeo Lozano
repository.mail.fl_str_mv expeditio@utadeo.edu.co
_version_ 1814213513766240256
spelling 2020-09-16T14:53:36Z2020-09-16T14:53:36Z2020-06-150264-410Xhttps://www.sciencedirect.com/science/article/pii/S0264410X20308306?via%3Dihubhttp://hdl.handle.net/20.500.12010/13328https://doi.org/10.1016/j.vaccine.2020.06.0446 páginasapplication/pdfengVaccinereponame:Expeditio Repositorio Institucional UJTLinstname:Universidad de Bogotá Jorge Tadeo LozanoBrighton CollaborationCEPIVaccineBenefit-riskSafetyProteinRecombinantPeptideTemplateSíndrome respiratorio agudo graveCOVID-19SARS-CoV-2CoronavirusThe Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccinesArtículohttp://purl.org/coar/resource_type/c_6501Acceso restringidohttp://purl.org/coar/access_right/c_16ecSeveral protein vaccine candidates are among the COVID-19 vaccines in development. The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) has prepared a standardized template to describe the key considerations for the benefit-risk assessment of protein vaccines. This will help key stakeholders to assess potential safety issues and understand the benefit-risk of such a vaccine platform. The structured and standardized assessment provided by the template would also help contribute to improved public acceptance and communication of licensed protein vaccines.Kochhar, SonaliKim, DennyExcler, ean-LouisCondit, Richard C.Robertson, James S.Drew, StephenWhelan, MikeWood, DavidFast, Patricia E.Gurwith, MarcKlug, BettinaKhuri-Bulos, NajwaSmith, Emily R.Chen, Robert TFor the Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG)LICENSElicense.txtlicense.txttext/plain; charset=utf-82938https://expeditiorepositorio.utadeo.edu.co/bitstream/20.500.12010/13328/2/license.txtabceeb1c943c50d3343516f9dbfc110fMD52open accessORIGINALThe Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines.pdfThe Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines.pdfDocumento Reservadoapplication/pdf279210https://expeditiorepositorio.utadeo.edu.co/bitstream/20.500.12010/13328/3/The%20Brighton%20Collaboration%20standardized%20template%20for%20collection%20of%20key%20information%20for%20benefit-risk%20assessment%20of%20protein%20vaccines.pdf577f0dded44f9b81cbc5aacb5644ae3cMD53embargoed access|||2420-09-16THUMBNAILThe Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines.pngThe Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines.pngimage/png100912https://expeditiorepositorio.utadeo.edu.co/bitstream/20.500.12010/13328/4/The%20Brighton%20Collaboration%20standardized%20template%20for%20collection%20of%20key%20information%20for%20benefit-risk%20assessment%20of%20protein%20vaccines.pngc45af434de2d32e6c8bc0434faf5d57dMD54open accessThe Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines.pdf.jpgThe Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines.pdf.jpgIM Thumbnailimage/jpeg13139https://expeditiorepositorio.utadeo.edu.co/bitstream/20.500.12010/13328/5/The%20Brighton%20Collaboration%20standardized%20template%20for%20collection%20of%20key%20information%20for%20benefit-risk%20assessment%20of%20protein%20vaccines.pdf.jpgfb4b23cc8fd4f8c0d08881f49ee2ec4dMD55open access20.500.12010/13328oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/133282020-09-16 09:54:56.677embargoed access|||2420-09-16Repositorio Institucional - Universidad Jorge Tadeo Lozanoexpeditio@utadeo.edu.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